tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RVPH Stock Latest News

Reviva Pharmaceuticals announces vocal biomarker data from RECOVER trial
The FlyReviva Pharmaceuticals announces vocal biomarker data from RECOVER trial
11d ago
RVPH
Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
PremiumPress Releases
Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
11d ago
RVPH
Reviva Pharmaceuticals to hold a virtual key opinon leader event
PremiumThe Fly
Reviva Pharmaceuticals to hold a virtual key opinon leader event
16d ago
RVPH
Reviva to host KOL event on vocal biomarker data from RECOVER trial
PremiumThe Fly
Reviva to host KOL event on vocal biomarker data from RECOVER trial
24d ago
RVPH
Reviva Pharmaceuticals Launches Multi-Million Share Offering
PremiumCompany Announcements
Reviva Pharmaceuticals Launches Multi-Million Share Offering
30d ago
8K
RVPH
Reviva Pharmaceuticals 4.76M share Secondary priced at $1.05
PremiumThe FlyReviva Pharmaceuticals 4.76M share Secondary priced at $1.05
1M ago
RVPH
Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules
Premium
Press Releases
Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules
1M ago
RVPH
Reviva Pharmaceuticals downgraded to Hold from Buy at Maxim
Premium
The Fly
Reviva Pharmaceuticals downgraded to Hold from Buy at Maxim
1M ago
RVPH
Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights
PremiumPress Releases
Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights
1M ago
RVPH
Reviva Pharmaceuticals announces anticipated milestones
PremiumThe Fly
Reviva Pharmaceuticals announces anticipated milestones
1M ago
RVPH
Reviva Pharmaceuticals reports Q2 EPS (26c), consensus (29c)
PremiumThe Fly
Reviva Pharmaceuticals reports Q2 EPS (26c), consensus (29c)
1M ago
RVPH
Reviva announces grant of U.S. patent covering use of brilaroxazine
PremiumThe Fly
Reviva announces grant of U.S. patent covering use of brilaroxazine
2M ago
RVPH
Reviva Pharmaceuticals Secures European Patent for Brilaroxazine
PremiumCompany AnnouncementsReviva Pharmaceuticals Secures European Patent for Brilaroxazine
2M ago
8K
RVPH
Reviva Pharmaceuticals announces grant of European patent on brilaroxazine
Premium
The Fly
Reviva Pharmaceuticals announces grant of European patent on brilaroxazine
2M ago
RVPH
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension
Premium
Press Releases
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension
2M ago
RVPH
Reviva Pharmaceuticals price target lowered to $14 from $20 at H.C. Wainwright
PremiumThe Fly
Reviva Pharmaceuticals price target lowered to $14 from $20 at H.C. Wainwright
3M ago
RVPH
Reviva to Participate in the BIO International Convention
PremiumPress Releases
Reviva to Participate in the BIO International Convention
4M ago
RVPH
Reviva Pharmaceuticals Progresses with Global Schizophrenia Trial
PremiumCompany Announcements
Reviva Pharmaceuticals Progresses with Global Schizophrenia Trial
4M ago
8K
RVPH
Reviva announces enrollment update for OLE study on brilaroxazine
PremiumThe Fly
Reviva announces enrollment update for OLE study on brilaroxazine
4M ago
RVPH
Reviva Pharmaceuticals Operational Performance Insights
PremiumCompany AnnouncementsReviva Pharmaceuticals Operational Performance Insights
4M ago
8K
RVPH
Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
Premium
Press Releases
Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
4M ago
RVPH
Reviva Pharmaceuticals reports Q1 EPS (25c), consensus (38c)
Premium
The Fly
Reviva Pharmaceuticals reports Q1 EPS (25c), consensus (38c)
4M ago
RVPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >